July CLE - John E. Schneider CEO and founder of Avalon Health Economics
July 8, 2026
John E. Schneider is the CEO and founder of Avalon Health Economics. His PhD is in Health Services and Policy Analysis from the University of California Berkeley, with a concentration in health economics. He has over 30 years of experience studying economic and organizational aspects of the health care industry. Dr. Schneider’s expertise include: economic evaluation of new pharmaceuticals, devices, and diagnostics; pricing and reimbursement; analysis of medical care costs; health insurance & managed care; regulation, hospital competition, and health care markets; specialty hospitals; physician ownership; contracting; antitrust; and trademark infringement.
In This CLE Dr. Schneider will speak on his new book "The Economics of Pain: Regulation, Product Liability, and the Opioid Crisis"
The primary goal of this book is to use the experiences of the opioid crisis and opioid product liability litigation in the United States as examples of how we can improve our understanding of complex healthcare issues and problems, including the thorough assessment of causal factors and a more precise estimation of the impact of harms and externalities. The identification of causal factors is critical to preventing similar problems in the future, and greater precision in the estimation of attributable costs and abatement costs is essential to product liability litigation. The secondary objective of the book is to use the experiences and data from the opioid crisis to explore remedies to similar, seemingly intractable problems. In addition to targeted abatement programs, there is a need to sort through the costs and benefits of alternative forms of governance for higher risk prescription drugs, which inevitably will require reforming regulatory procedures and exploiting the costs and benefits of court ordering for those circumstances where regulation fails.
